MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1

MicroRNAs are well acknowledged as key mediators in the development of chronic metabolic diseases, including NAFLD. However, their roles in hepatic lipid metabolism and fatty liver still remain well elucidated. Here, we found that miR-103 represses de novo lipogenesis (DNL) and dampens the developme...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Biochemical and biophysical research communications Ročník 524; číslo 3; s. 716 - 722
Hlavní autori:	Zhang, Meiyuan, Tang, Yan, Tang, E., Lu, Weirong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 09.04.2020
Predmet:	de novo lipogenesis fatty liver hepatocytes homeostasis lipids lipogenesis liver mice microRNA miR-103 NAFLD Obesity pathogenesis miR-103 Obesity NAFLD de novo lipogenesis
ISSN:	0006-291X, 1090-2104, 1090-2104
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!